-
Musona rescues Zimbabwe in AFCON draw with Angola
-
Zelensky to meet Trump in Florida on Sunday
-
'Personality' the key for Celtic boss Nancy when it comes to new signings
-
Arteta eager to avoid repeat of Rice red card against Brighton
-
Nigeria signals more strikes likely in 'joint' US operations
-
Malaysia's former PM Najib convicted in 1MDB graft trial
-
Elusive wild cat feared extinct rediscovered in Thailand
-
Japan govt approves record budget, including for defence
-
Malaysia's Najib convicted of abuse of power in 1MDB graft trial
-
Seoul to ease access to North Korean newspaper
-
History-maker Tongue wants more of the same from England attack
-
Australia lead England by 46 after 20 wickets fall on crazy day at MCG
-
Asia markets edge up as precious metals surge
-
Twenty wickets fall on day one as Australia gain edge in 4th Ashes Test
-
'No winner': Kosovo snap poll unlikely to end damaging deadlock
-
Culture being strangled by Kosovo's political crisis
-
Main contenders in Kosovo's snap election
-
Australia all out for 152 as England take charge of 4th Ashes Test
-
Boys recount 'torment' at hands of armed rebels in DR Congo
-
Inside Chernobyl, Ukraine scrambles to repair radiation shield
-
Bondi victims honoured as Sydney-Hobart race sets sail
-
North Korea's Kim orders factories to make more missiles in 2026
-
Palladino's Atalanta on the up as Serie A leaders Inter visit
-
Hooked on the claw: how crane games conquered Japan's arcades
-
Shanghai's elderly waltz back to the past at lunchtime dance halls
-
Japan govt approves record 122 trillion yen budget
-
US launches Christmas Day strikes on IS targets in Nigeria
-
Australia reeling on 72-4 at lunch as England strike in 4th Ashes Test
-
Too hot to handle? Searing heat looming over 2026 World Cup
-
Packers clinch NFL playoff spot as Lions lose to Vikings
-
Guinea's presidential candidates hold final rallies before Sunday's vote
-
Calvin B. Taylor Bankshares, Inc. Reports Third Quarter Financial Results and Announces New Stock Repurchase Program
-
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
-
Loar Holdings Inc. Announced The Completion of its Acquisition of LMB Fans & Motors
-
IRS Can Freeze Installment Agreements After Missed Filings - Clear Start Tax Explains Why Compliance Comes First
-
How the Terms of SMX's $111 Million Capital Facility Shape the Valuation Discussion
-
A Christmas Message to the DEA's Diversion Anti Marijuana Cabal
-
QAT Community Sets QuantumTrade 5.0 for Public Beta Testing in March 2026
-
BondwithPet Expands B2B Offering with Custom Pet Memorial Product
-
Best Crypto IRA Companies (Rankings Released)
-
Eon Prime Intelligent Alliance Office Unveils New Brand Identity and Completes Website Upgrade
-
Villa face Chelsea test as Premier League title race heats up
-
Spurs extend domination of NBA-best Thunder
-
Malaysia's Najib to face verdict in mega 1MDB graft trial
-
Russia makes 'proposal' to France over jailed researcher
-
King Charles calls for 'reconciliation' in Christmas speech
-
Brazil's jailed ex-president Bolsonaro undergoes 'successful' surgery
-
UK tech campaigner sues Trump administration over US sanctions
-
New Anglican leader says immigration debate dividing UK
RFK Jr's medical panel to revisit debunked vaccine claims
A vaccine panel appointed by US Health Secretary Robert F. Kennedy Jr. will revisit long-settled science and spotlight rare risks linked to childhood immunizations in a meeting beginning Wednesday, raising fears that fringe theories could seep into national policy.
The Advisory Committee on Immunization Practices (ACIP), an independent body that reviews scientific evidence to recommend which groups should receive vaccines and when, rarely makes headlines.
But these are no ordinary times. Kennedy, who spent two decades spreading vaccine misinformation before becoming President Donald Trump's top health official, has brought that skepticism into the federal government.
Earlier this month he abruptly dismissed all 17 ACIP members before their terms had expired, accusing them of financial ties to the pharmaceutical industry -- despite a vetting process meant to minimize conflicts of interest.
He then appointed eight new members, including scientist Robert Malone, widely known for spreading false claims during the Covid-19 pandemic and promoting the deworming drug ivermectin.
The posted agenda includes standard topics like influenza and Covid-19 vaccines -- but the addition, on the second day of discussions, of measles, mumps, rubella, and varicella (MMRV) vaccines for young children, along with thimerosal-containing flu shots, has alarmed experts.
Ahead of the meeting, US senator and physician Bill Cassidy -- a Republican whose reluctant support was key to Kennedy's confirmation -- called for a delay, citing the panelists' inexperience and bias.
- Debunked autism connection -
Thimerosal is a mercury-based preservative long used in medicines, with no evidence of harm at low doses.
"Study after study showed that the ethylmercury in those vaccines never contributed in any important way to the burden of mercury that one is exposed to, living on this planet," vaccine expert Paul Offit of the Children's Hospital of Philadelphia told AFP.
Still, vaccine makers agreed to remove it from pediatric vaccines in 1999 in response to public concern. It remains in some flu shots.
The presenter arguing against thimerosal is Lyn Redwood, a nurse and former leader of Children's Health Defense — an anti-vaccine nonprofit once chaired by RFK Jr.
According to her biography page, Redwood blames her son's autism on vaccines -- a link that has never been proven.
The Centers for Disease Control and Prevention, which is overseeing the meeting, will argue thimerosal is safe and has no effect on neurodevelopment, based on a thorough review of the evidence.
- Rampant measles outbreak -
For childhood vaccines, US parents can choose a combined measles, mumps, rubella, and varicella (MMRV) shot or two separate injections -- one for MMR, the other for varicella.
The combination spares an extra jab but carries a slightly higher risk of febrile seizures, a rare and typically harmless side effect.
Separating the shots is already recommended for infants' first dose at age 12-47 months, leaving experts puzzled as to why the issue is being revisited. Notably, there's no planned discussion on the benefits of measles vaccines, which have prevented millions of hospitalizations.
"The discussion of MMRV vaccines, critical tools in preventing measles, mumps, rubella, and varicella, must be rooted in science, not ideology," said Syra Madad, an infectious disease epidemiologist at NYC Health + Hospitals.
The United States, which declared measles eliminated in 2000, is currently experiencing its worst measles outbreak of the disease in decades, with more than 1,200 cases and three confirmed deaths.
"ACIP is going to become an outlet for anti-vaccine propaganda and increasingly irrelevant to the practice of medicine," warned Amesh Adalja, an infectious disease expert at Johns Hopkins University.
Still, the panel's recommendations could have broad consequences, shaping school vaccine mandates and insurance coverage.
P.Hernandez--AT